戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                           Of the 229 patients enrolled, 153 were randomly assigned to receive luspatercept and 76 to rece
2                                         Of these, 197 (34%) were randomly assigned to receive 150 mg S44819 twice a day,
3 ts, of whom 59 were randomly assigned to tocilizumab and 59 were randomly assigned to azathioprine.
4 2017, and Aug 3, 2018, we enrolled 118 patients, of whom 59 were randomly assigned to tocilizumab and 59 were randomly as
5 = 70 [24.4%]; MPNST: n = 27 [9.4%]; and LMS: n = 28 [9.8%]) were randomly assigned to either A+I or HT.
6  computer-generated list, T. trichiura-infected adolescents were randomly assigned to 7 treatment arms: 8, 16, or 24 mg o
7  Fifty-four childcare centers in New South Wales, Australia were randomly assigned to the intervention (a web-based menu-
8 ergoing elective colon resection for nonmetastasized cancer were randomly assigned to 2 intravenous n-3 PUFA or saline co
9                                              15 communities were randomly assigned to receive HIV prevention and treatmen
10 tatic urothelial carcinoma, from 221 sites in 35 countries, were randomly assigned to receive atezolizumab plus platinum-
11 ocardial infarction and multivessel coronary artery disease were randomly assigned to one of the following revascularizat
12      Between Oct 1, 2016, and April 30, 2019, 20 facilities were randomly assigned to either the intervention group (n=10
13  who were recently hospitalized for worsening heart failure were randomly assigned to receive sotagliflozin or placebo.
14 ), with refractory agitation, despite low-dose haloperidol, were randomly assigned to receive intravenous haloperidol dos
15     Between June 14, 2015 and Jul 11, 2017, 60 men with HIV were randomly assigned to receive either an ART-only (n=30) o
16 ovember 2016 through November 2017, a total of 1453 infants were randomly assigned to receive nirsevimab (969 infants) or
17 ), abdominally obese or dyslipidemic participants in Israel were randomly assigned to healthy dietary guidelines, Mediter
18  or IIIC (without in-transit metastasis) cutaneous melanoma were randomly assigned to receive pembrolizumab at a flat dos
19                                  Groups of 8 weeks old mice were randomly assigned to receive chow diet, high fat diet wi
20 igible (TIE) patients with newly diagnosed multiple myeloma were randomly assigned to D-Rd (n = 368) or Rd (n = 369).
21                                                Participants were randomly assigned to 8 weeks of monitored feeding with a
22                                                Participants were randomly assigned to a 52-minute intravenous administrat
23                                                Participants were randomly assigned to a 6-week intranasal oxytocin (48IU/
24                                                Participants were randomly assigned to either GumChucks or SF.
25                                                Participants were randomly assigned to either undergo prophylactic negativ
26                                                Participants were randomly assigned to once-daily oral fixed-dose combinat
27                                                Participants were randomly assigned to one of five groups and then further
28                                                Participants were randomly assigned to wear high add power (n = 98), mediu
29 week lead-in period of cognitive training, 100 participants were randomly assigned to receive either vortioxetine or plac
30                                A total of 3030 participants were randomly assigned to the recommendation to wear masks, a
31 5, 1027 individuals were screened, of whom 769 participants were randomly assigned to doravirine (n=385) or ritonavir-boo
32 he time of percutaneous coronary intervention, participants were randomly assigned to prospective rapid point-of-care gen
33                                    Thirty-nine participants were randomly assigned to bilateral PS (n = 14), monolateral
34               In the historical control trial, participants were randomly assigned to either one dose or two doses of mon
35                                 IPV-vaccinated participants were randomly assigned to receive two doses of either novel O
36                                                    Patients were randomly assigned to catheter ablation alone (n = 158) o
37                                                    Patients were randomly assigned to hydroxychloroquine (400 mg twice da
38                                                    Patients were randomly assigned to the short-term (8 to 10 weeks) or l
39                  From September 2014 to June 2018, patients were randomly assigned to groups that received the prophylaxi
40       Between July 19, 2016, and Oct 31, 2017, 291 patients were randomly assigned to receive venetoclax (n=194) or place
41      Between July 31, 2013, and June 22, 2015, 437 patients were randomly assigned to either placebo (n=108) or cenobamat
42      Between March 11, 2016, and June 22, 2018, 62 patients were randomly assigned to nivolumab (n = 30) or nivolumab plu
43 nfirmation of TNBC status by immunohistochemistry, patients were randomly assigned to either capecitabine or observation.
44                           In the PARTNER 2A trial, patients were randomly assigned to receive either TAVR with the SAPIEN
45 ed to be deriving benefit despite radiographic progression, were randomly assigned to continue nivolumab until disease pr
46  metastatic CRC previously treated with one or two regimens were randomly assigned to irinotecan and cetuximab with or wi
47 -wk run-in period on a nitrate-restricted diet the subjects were randomly assigned to receive 1 of the following 3 interv
48                      After this initial treatment, subjects were randomly assigned to group 1 (1 TMP-SMZ dose every other
49 emala included 26 mother-infant dyads 4-6 mo postpartum who were randomly assigned to receive 3 treatments in a random or
50                Overall, 44 clusters (69 330 pregnant women) were randomly assigned to intervention (22 clusters [36 008 p